Pancreatic Cancer Non-resectable
Showing 1 - 25 of >10,000
Pancreatic Cancer Non-resectable Trial (collection of blood and tumor samples)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- collection of blood and tumor samples
- (no location specified)
Mar 27, 2023
Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- +12 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 30, 2022
Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial in Baltimore (INCMGA00012 (PD-1 antibody))
Recruiting
- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Metastatic
- INCMGA00012 (PD-1 antibody)
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 16, 2022
Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreas Cancer
- Non-Resectable Pancreas Carcinoma
- Gemcitabine
- Nab paclitaxel
-
Aalborg, DenmarkDepartment of Oncology, Aalborg University Hospital
May 1, 2023
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Focused Ultrasound
- +2 more
-
Oxford, United KingdomOxford University Hospitals NHS Trust
Feb 22, 2022
Pancreatic Cancer Non-resectable Trial in Shanghai (Carbon ion radiotherapy)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- Carbon ion radiotherapy
-
Shanghai, ChinaShanghai Proton and Heavy Ion Center
Jun 22, 2022
Thoracic Cancer, Pancreatic Cancer Non-resectable, Brain Cancer Trial (Proton Radiation)
Not yet recruiting
- Thoracic Cancer
- +4 more
- Proton Radiation
- (no location specified)
Sep 19, 2022
Pancreatic Cancer Non-resectable, Chemo Effect, Ultrasound Therapy Trial in Seoul (ALPIUS 900, an ultrasound-guided high
Recruiting
- Pancreatic Cancer Non-resectable
- +2 more
- ALPIUS 900, an ultrasound-guided high intensity focused ultrasound system
- FOLFIRINOX regimen
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 20, 2022
Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable Trial in Seoul (SBRT+mFOLFIRINOX, mFOLFIRINOX)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Cancer Non-resectable
- SBRT+mFOLFIRINOX
- mFOLFIRINOX
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 24, 2022
Pancreatic Cancer Non-resectable Trial in Amsterdam, Utrecht (stereotactic ablative radiotherapy)
Recruiting
- Pancreatic Cancer Non-resectable
- stereotactic ablative radiotherapy
-
Amsterdam, Noord-Holland, Netherlands
- +1 more
Feb 22, 2022
Resectable Pancreatic Cancer Trial in Denmark (ctDNA)
Recruiting
- Resectable Pancreatic Cancer
- ctDNA
-
Aalborg, Denmark
- +4 more
Mar 27, 2023
Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic Trial (Irinotecan Liposome Injection, Fluorouracil, Leucovorin)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Metastatic
- Irinotecan Liposome Injection
- +5 more
- (no location specified)
Sep 16, 2021
Viewpoints on Social Representations and Rationale Concerning
Terminated
- Non-resectable Metastatic Cancer of the Lung
- +7 more
- Interviews
- Questionnaires
-
Dijon, FranceChu Dijon Bourogne
Apr 14, 2022
Candidates for Neoadjuvant Treatment in Resectable Pancreatic
Completed
- Pancreatic Cancer
- Neoadjuvant
- Neoadjuvant treatment
- (no location specified)
Nov 9, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Dose-Painted Intensity Modulated Radiotherapy
-
Dublin, IrelandSt Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023
Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Carcinoma
- Toripalimab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023
Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in
Not yet recruiting
- Pancreas Adenocarcinoma
- +2 more
- Nab paclitaxel
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Pancreatic Cancer Non-resectable, Chemo-induced Nausea and Vomiting, Pancreatic Cancer Metastatic Trial in Austria, Germany
Recruiting
- Pancreatic Cancer Non-resectable
- +2 more
- Dronabinol in Oral Dosage Form
- Placebo in Oral Dosage Form
-
Wels, Oberösterreich, Austria
- +10 more
Jan 18, 2022
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)
Suspended
- Borderline Resectable Pancreatic Cancer
- Intraoperative radiotherapy
-
Verona, ItalyGeneral and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022